Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MONTELUKAST Cause Therapy non-responder? 99 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 99 reports of Therapy non-responder have been filed in association with MONTELUKAST (Montelukast). This represents 0.4% of all adverse event reports for MONTELUKAST.

99
Reports of Therapy non-responder with MONTELUKAST
0.4%
of all MONTELUKAST reports
2
Deaths
7
Hospitalizations

How Dangerous Is Therapy non-responder From MONTELUKAST?

Of the 99 reports, 2 (2.0%) resulted in death, 7 (7.1%) required hospitalization, and 6 (6.1%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 99 reports have been filed with the FAERS database.

What Other Side Effects Does MONTELUKAST Cause?

Asthma (8,372) Dyspnoea (6,354) Wheezing (5,159) Drug ineffective (3,539) Cough (3,475) Therapeutic product effect incomplete (3,352) Anxiety (2,994) Loss of personal independence in daily activities (2,736) Sleep disorder due to a general medical condition (2,101) Obstructive airways disorder (2,073)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which MONTELUKAST Alternatives Have Lower Therapy non-responder Risk?

MONTELUKAST vs MONTELUKAST\MONTELUKAST MONTELUKAST vs MONTMORILLONITE MONTELUKAST vs MORNIFLUMATE MONTELUKAST vs MOROCTOCOG ALFA MONTELUKAST vs MORPHINE

Related Pages

MONTELUKAST Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder MONTELUKAST Demographics